EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Anticoagulation and Thrombolysis

Michael Q Dong, Tania Ahuja, Geno Merli, Rachel P Rosovsky, Beverley J Hunt, James M Horowitz, Frances Mae West

Clinics in Chest Medicine · 2026-12 · 47 (4) · 747-757

DOI: 10.1016/j.ccm.2026.07.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Chest Medicine, 2026-12. Verfasst von Michael Q Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Electronic address: michael.dong@jefferson.edu. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Anticoagulants, Pulmonary Embolism, Fibrinolytic Agents. Die Arbeit nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary embolism is a life-threatening condition requiring prompt anticoagulation to prevent clot propagation and recurrence. Risk stratification guides therapy, with systemic thrombolysis reserved for high-risk patients and selected intermediate-high risk cases due to significant bleeding risk. Direct oral anticoagulants are preferred for most low and intermediate-low risk patients, while low-molecular-weight heparin and unfractionated heparin remain critical for higher- risk or procedurally complex cases. Emerging strategies including low-dose thrombolysis, catheter-directed therapies, and the future use of Factor XI inhibitors may improve safety without compromising efficacy. Management of bleeding complications necessitates rapid intervention, reversal when available, and coordinated multidisciplinary care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombolytic TherapyAnticoagulantsPulmonary EmbolismFibrinolytic AgentsHumansHeparin

Stichwörter der Autor:innen

AnticoagulationPulmonary embolismThrombolysisUnfractionated heparin

Substanzen

AnticoagulantsFibrinolytic AgentsHeparin

Autor:innen und Institutionen

  • Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Electronic address: michael.dong@jefferson.edu.
  • Department of Pharmacy, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA.
  • Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
  • Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Thrombosis & Haemostasis, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Department of Internal Medicine/ Cardiology, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA.

Zitieren

APA

Dong, M. Q., Ahuja, T., Merli, G., Rosovsky, R. P., Hunt, B. J., Horowitz, J. M., & West, F. M. (2026). Anticoagulation and Thrombolysis. Clinics in Chest Medicine, 47(4), 747-757. https://doi.org/10.1016/j.ccm.2026.07.007

Vancouver

Dong MQ, Ahuja T, Merli G, Rosovsky RP, Hunt BJ, Horowitz JM, et al. Anticoagulation and Thrombolysis. Clinics in Chest Medicine. 2026;47(4):747-757. doi:10.1016/j.ccm.2026.07.007

BibTeX
@article{Dong2026,
  author = {Dong, Michael Q and Ahuja, Tania and Merli, Geno and Rosovsky, Rachel P and Hunt, Beverley J and Horowitz, James M and West, Frances Mae},
  title = {Anticoagulation and Thrombolysis},
  journal = {Clinics in Chest Medicine},
  year = {2026},
  volume = {47},
  number = {4},
  pages = {747--757},
  doi = {10.1016/j.ccm.2026.07.007}
}
Kostenlos starten →